Integrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategies
From MaRDI portal
Publication:1794907
DOI10.1016/j.jtbi.2008.02.016zbMath1398.92133OpenAlexW2168700995WikidataQ36840074 ScholiaQ36840074MaRDI QIDQ1794907
Neil S. Forbes, Michael A. Henson, Raja Venkatasubramanian
Publication date: 16 October 2018
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2008.02.016
PDEs in connection with biology, chemistry and other natural sciences (35Q92) Medical applications (general) (92C50) Cell biology (92C37)
Related Items
The effects of a telomere destabilizing agent on cancer cell-cycle dynamics -- integrated modelling and experiments, Tissue transport affects how treatment scheduling increases the efficacy of chemotherapeutic drugs, Targeting the quiescent cells in cancer chemotherapy treatment: is it enough?
Cites Work
- Regression and regrowth of tumour cords following single-dose anticancer treatment
- A mathematical model of breast and ovarian cancer treated with Paclitaxel
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
- Modelling cell death in human tumour cell lines exposed to the anticancer drug paclitaxel
- Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures
- A mathematical model for analysis of the cell cycle in cell lines derived from human tumors
- Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model
- Using Krylov Methods in the Solution of Large-Scale Differential-Algebraic Systems
- USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS
- Unnamed Item
- Unnamed Item